|
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC |
|
|
|
Titel: |
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC |
Auteur: |
Bando, Hideaki Kotani, Daisuke Satake, Hironaga Hamaguchi, Tetsuya Shiozawa, Manabu Kotaka, Masahito Masuishi, Toshiki Yasui, Hisateru Kagawa, Yoshinori Komatsu, Yoshito Oki, Eiji Yamamoto, Yoshiyuki Kawakami, Hisato Misumi, Toshihiro Taniguchi, Hiroya Yamazaki, Kentaro Muro, Kei Yoshino, Takayuki Kato, Takeshi Tsuji, Akihito |
Verschenen in: |
Med |
Paginering: |
Jaargang 5 () nr. 9 pagina's 1164-1177.e3 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|